This case report outlines the efficacy of repeated low-dose ketamine infusions (<35mg/70kg) as an adjuvant pain control medication for a terminally-ill cancer patient. The patient reported a sustained reduction in pain level and a reduction of total opioid usage in response to three consecutive ketamine infusions, which implicates its utility for improving the treatment of refractory pain within palliative care.
- Published
- Journal
- Annals of Palliative Medicine
- Authors
- Fattakhov, E., Galea, J., Kaur, G., Patel, S., Singh, A. B., Tatachar, V.